EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of blood metabolites in mediating the effect of gut microbiome on the mutated-RAS/BRAF metastatic colorectal cancer-specific survival

Yaoxian Xiang, Chan Zhang, Jing Wang, Yurong Cheng, Kangjie Wang, Li Wang, Yingying Tong, Dong Yan

International Journal of Colorectal Disease · 2024

DOI: 10.1007/s00384-024-04686-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Colorectal Disease, 2024. Verfasst von Yaoxian Xiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, 101149, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Gastrointestinal Microbiome, Proto-Oncogene Proteins B-raf, Mutation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Capital Health Research and Development of Special Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recent studies have linked alterations in the gut microbiome and metabolic disruptions to the invasive behavior and metastasis of colorectal cancer (CRC), thus affecting patient prognosis. However, the specific relationship among gut microbiome, metabolite profiles, and mutated-RAS/BRAF metastatic colorectal cancer (M-mCRC) remains unclear. Furthermore, the potential mechanisms and prognostic implications of metabolic changes induced by gut microbiome alterations in patients with M-mCRC still need to be better understood.

Methods

We conducted Mendelian randomization (MR) to evaluate the causal relationship of genetically predicted 196 gut microbiome features and 1400 plasma metabolites/metabolite ratios on M-mCRC-specific survival. Additionally, we identified significant gut microbiome-metabolites/metabolite ratio associations based on M-mCRC. Metabolite information was annotated, and functional annotation and pathway enrichment analyses were performed on shared proteins corresponding to significant metabolite ratios, aiming to reveal potential mechanisms by which gut microbiome influences M-mCRC prognosis via modulation of human metabolism.

Results

We identified 11 gut microbiome features and 49 known metabolites/metabolite ratios correlated with M-mCRC-specific survival. Furthermore, we identified 17 gut microbiome-metabolite/metabolite ratio associations specific to M-mCRC, involving eight lipid metabolites and three bilirubin degradation products. The shared proteins corresponding to significant metabolite ratios were predominantly localized within the integral component of the membrane and exhibited enzymatic activities such as glucuronosyltransferase and UDP-glucuronosyltransferase, crucial in processes such as glucuronidation, bile secretion, and lipid metabolism. Moreover, these proteins were significantly enriched in pathways related to ascorbate and aldarate metabolism, pentose and glucuronate interconversions, steroid hormone biosynthesis, and bile secretion.

Conclusion

Our study offers novel insights into the potential mechanisms underlying the impact of the gut microbiome on the prognosis of M-mCRC. These findings serve as a meaningful reference for exploring potential therapeutic targets and strategies in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsGastrointestinal MicrobiomeProto-Oncogene Proteins B-rafMutationNeoplasm MetastasisHumansPrognosisMendelian Randomization AnalysisSurvival Analysisras ProteinsMetabolome

Stichwörter der Autor:innen

Causal relationshipGut microbiomeMendelian randomization(MR)MetabolitesMutated-RAS/BRAF metastatic colorectal cancer(M-mCRC)Survival

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, humanras Proteins

Autor:innen und Institutionen

  • Department of Oncology, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, 101149, China.
  • Department of Oncology, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, 101149, China. yd15yt88@163.com.

Förderung

  • Capital Health Research and Development of Special Fund

Zitieren

APA

Xiang, Y., Zhang, C., Wang, J., Cheng, Y., Wang, K., Wang, L., Tong, Y., & Yan, D. (2024). Role of blood metabolites in mediating the effect of gut microbiome on the mutated-RAS/BRAF metastatic colorectal cancer-specific survival. International Journal of Colorectal Disease. https://doi.org/10.1007/s00384-024-04686-9

Vancouver

Xiang Y, Zhang C, Wang J, Cheng Y, Wang K, Wang L, et al. Role of blood metabolites in mediating the effect of gut microbiome on the mutated-RAS/BRAF metastatic colorectal cancer-specific survival. International Journal of Colorectal Disease. 2024. doi:10.1007/s00384-024-04686-9

BibTeX
@article{Xiang2024,
  author = {Xiang, Yaoxian and Zhang, Chan and Wang, Jing and Cheng, Yurong and Wang, Kangjie and Wang, Li and Tong, Yingying and Yan, Dong},
  title = {Role of blood metabolites in mediating the effect of gut microbiome on the mutated-RAS/BRAF metastatic colorectal cancer-specific survival},
  journal = {International Journal of Colorectal Disease},
  year = {2024},
  doi = {10.1007/s00384-024-04686-9}
}
Kostenlos starten →